highly significantp < 0.0001
Across nine sessions over three weeks, PBMT-sMF treatment led to a highly significant reduction in tender points and improved clinical impact scores ( p < 0.0001), with no adverse events.
Across nine sessions over three weeks, PBMT-sMF treatment led to a highly significant reduction in tender points and improved clinical impact scores ( p < 0.0001), with no adverse events.
Using a 940 nm diode laser at 0.3 W for 20, 30, or 40 s (energy densities of 69, 103, and 138 J/cm2), the authors reported a nonsignificant trend toward reduced pain with longer exposure times.